Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Sky One Medical: A Company on the Move

publication date: Dec 8, 2008

China Sky One Medical  (中国天字一号医药公司), as we are reminded almost weekly, is a tornado of activity, acquiring companies and bringing out new products at a pace unmatched in China biopharma. Last week, The China Perspective published an interview with Mr. Yan-qing Liu, CEO of China Sky One Medical (see article), an interview that reinforced the company-in-a-hurry theme. Nevertheless, despite its success, the stock remains priced very low relative to its prospects, probably due to the worldwide economic crisis. Using Mr. Lui’s latest interview as an excuse, we would like to take another look at the whirlwind that is China Sky One. More details...

Stock Symbol: (NSDQ: CSKI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital